<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BioMedGPT-Mol: Multi-task Learning for Molecular Understanding and Generation - Health AI Hub</title>
    <meta name="description" content="BioMedGPT-Mol is introduced as a novel molecular language model that leverages multi-task learning to enhance molecular understanding and generation for drug di">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>BioMedGPT-Mol: Multi-task Learning for Molecular Understanding and Generation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04629v1" target="_blank">2512.04629v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-04
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Chenyang Zuo, Siqi Fan, Zaiqing Nie
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04629v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04629v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">BioMedGPT-Mol is introduced as a novel molecular language model that leverages multi-task learning to enhance molecular understanding and generation for drug discovery. By post-training a general-purpose reasoning model on a curated, large-scale dataset, it achieves remarkable performance on molecular benchmarks and demonstrates competitive capabilities as an end-to-end retrosynthetic planner.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to medicine and health as it provides an advanced AI tool to accelerate critical stages of small molecule drug discovery and development. By improving molecular understanding, generation, and synthesis planning, it can expedite the identification and optimization of new therapeutic agents, potentially leading to faster drug development cycles.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>BioMedGPT-Mol is an AI molecular language model designed to enhance and accelerate small molecule drug development. It can be used by researchers to understand molecular properties, generate novel molecular structures (potential drug candidates), and plan the synthetic pathways (retrosynthetic planning) for these compounds, thereby streamlining the drug discovery and development pipeline.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>BioMedGPT-Mol is a new molecular language model designed for molecular understanding and generation tasks, crucial for small molecule drug development.</li>
                    
                    <li>It adapts general-purpose large language models (reasoning models) for molecular science through a specific post-training approach.</li>
                    
                    <li>A large-scale, comprehensive, and high-quality training dataset was assembled by curating and unifying existing public instruction datasets.</li>
                    
                    <li>The model was fine-tuned using a meticulously designed multi-task learning framework to achieve its specialized capabilities.</li>
                    
                    <li>BioMedGPT-Mol achieved remarkable performance across consolidated benchmarks, including LlaSMol, TOMG-Bench, and MuMOInstruct.</li>
                    
                    <li>The research demonstrates that a well-structured multi-task curriculum can effectively transform a general-purpose reasoning model into a professional molecular language model.</li>
                    
                    <li>The model showed competitive capability as an end-to-end retrosynthetic planner on RetroBench, facilitating the prediction of chemical synthesis pathways.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology involved curating and unifying diverse public instruction datasets to create a large-scale, comprehensive, and high-quality training dataset specific to molecular tasks. A general-purpose reasoning model was then fine-tuned on this dataset through a meticulously designed multi-task learning framework, resulting in BioMedGPT-Mol. Its performance was evaluated on consolidated molecular benchmarks (LlaSMol, TOMG-Bench, MuMOInstruct) and specifically for retrosynthetic planning on RetroBench.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary findings include BioMedGPT-Mol's remarkable performance across established molecular understanding and generation benchmarks. Crucially, it demonstrated that a general-purpose reasoning model can be effectively and efficiently specialized into a professional molecular language model via a structured multi-task learning curriculum. Furthermore, BioMedGPT-Mol showed competitive capabilities as an end-to-end retrosynthetic planner.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The clinical impact of BioMedGPT-Mol lies in its potential to significantly accelerate the preclinical phases of drug development. By streamlining the design, optimization, and synthesis planning of novel small molecule candidates, it could reduce the time and cost associated with bringing new drugs to market. This could lead to quicker access to innovative treatments for a wide range of diseases, ultimately benefiting patient care and public health.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly mention specific limitations. However, typical considerations for such models include the reliance on the quality and comprehensiveness of the training data, potential biases inherent in historical datasets, the need for experimental validation of generated molecular properties, and the computational resources required for large-scale deployment and inference.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors anticipate that their multi-task learning approach, which effectively adapts general-purpose reasoning models, can be extended to other biomedical scientific domains beyond molecular understanding and generation. This suggests broad applicability in diverse areas of AI-driven biomedical research.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Pharmaceutical Research</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Chemical Synthesis</span>
                    
                    <span class="tag">Biotechnology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">molecular understanding</span>
                    
                    <span class="tag tag-keyword">molecular generation</span>
                    
                    <span class="tag tag-keyword">multi-task learning</span>
                    
                    <span class="tag tag-keyword">large language models</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">retrosynthesis</span>
                    
                    <span class="tag tag-keyword">small molecules</span>
                    
                    <span class="tag tag-keyword">biomedical AI</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Molecules play a crucial role in biomedical research and discovery, particularly in the field of small molecule drug development. Given the rapid advancements in large language models, especially the recent emergence of reasoning models, it is natural to explore how a general-purpose language model can be efficiently adapted for molecular science applications. In this work, we introduce BioMedGPT-Mol, a molecular language model designed to support molecular understanding and generation tasks. By curating and unifying existing public instruction datasets, we have assembled a large-scale, comprehensive, and high-quality training dataset. The model is then fine-tuned through a meticulously designed multi-task learning framework. On a consolidated benchmark derived from LlaSMol, TOMG-Bench, and MuMOInstruct, BioMedGPT-Mol achieves remarkable performance. Our experimental results demonstrate that a general-purpose reasoning model can be effectively and efficiently post-trained into a professional molecular language model through a well-structured multi-task curriculum. Leveraging the power of it, we further explore retrosynthetic planning task, and the performance on RetroBench demonstrates its competitive capability of acting as an end-to-end retrosynthetic planner. We anticipate that our approach can be extended to other biomedical scientific domains.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>